Myasthenia Gravis Bulk Plasma
About: Myasthenia Gravis Bulk Plasma is collected via apheresis using Acid-Citrate-Dextrose Formula A (ACDA). Tested negative for HIV, HBV, and HCV, and ideal for immunology, biomarker discovery, and disease-specific assay development.
Myasthenia Gravis Bulk Plasma Collected via Apheresis in ACDA
Myasthenia Gravis Plasma is collected from IRB-consented donors diagnosed with Myasthenia Gravis, using apheresis and ACDA (Acid-Citrate-Dextrose Formula A) as the anticoagulant. This disease-state plasma supports immunological and biomarker research and is ideal for assay development and therapeutic discovery.
Product Features
- High-volume plasma collected via apheresis
- Anticoagulated using ACDA
- Tested and confirmed negative for HIV, HBV, and HCV
- Available fresh with custom volumes upon request
- IRB-approved informed consent and HIPAA-compliant handling
De-identified Donor Data
- Clinically confirmed diagnosis of Myasthenia Gravis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Clinical history and medication data available
Applications
- Disease-specific biomarker discovery
- Inflammatory and immunological assay development
- Proteomic, metabolomic, and cytokine profiling
- Therapeutic development and validation studies
Compliance and Quality Assurance
- Screened negative for HIV, HBV, and HCV
- IRB-approved collection with 21 CFR Part 11–compliant consent
- Standardized processing and cryopreservation protocols
Ordering & Customization
Myasthenia Gravis Bulk Plasma is available in standard or custom volumes. For documentation or international shipping, please contact learnmore@sanguinebio.com.
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – with the exception of GMP leukopaks, all our products are research use only (RUO).
1 Answer
Our complete catalog can be found here: https://sanguinebio.com/products/
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Bulk Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.